CME test the key support area

CME Group is currently trading in the low‐$260s, with analysts’ consensus 12-month price targets ranging from approximately $260.60 (MarketBeat, StockAnalysis) to $287+ (Zacks, TipRanks), suggesting upside potential of roughly 5-10% from current levels

The company shows steady revenues from clearing & transaction fees, benefiting from macro volatility, hedging demand, and expanding global derivatives activity.

Technically, the chart is positioned near the 200-day moving average, which might represent a potentially good trade location for the strategic reversal and development of the upswing.

Don't forget - this is just the idea, make your own research and manage risk at all times!